OBJECTIVES: To evaluate the association between vitamin D level and cognitive impairment in individuals aged 60 and older. DESIGN: Cross-sectional cohort study. SETTING: Chinese Longitudinal Healthy Longevity Survey, a community-based cohort study in areas in China where the density of centenarians is exceptionally high. PARTICIPANTS: Individuals with mean age of 84.9 ± 12.7 (N = 2,004). MEASUREMENTS: Participants' cognitive state was evaluated using the Mini-Mental State Examination (MMSE). Vitamin D was measured in plasma using an enzyme-linked immunoassay. RESULTS: The cross-sectional association between quartiles of plasma vitamin D level and cognitive impairment (MMSE score <18) was modeled using logistic regressions. Plasma vitamin D levels were lower in individuals with cognitive impairment (31.9 ± 15.3 nmol/L) than in those without (45.6 ± 19.6 nmol/L). There was a reverse association between plasma vitamin D and cognitive impairment. After adjusting for age, sex, chronic conditions, smoking and drinking habits, outdoor activities, depression, and activity of daily living limitations, the association remained significant. The multivariable-adjusted odds ratio for lowest versus highest vitamin D levels was 2.15 (95% confidence interval (CI) = 1.05-4.41) for cognitive impairment, and the multivariable odds ratio associated with a 1-standard deviation decrement in plasma vitamin D was 1.32 (95% CI = 1.00-1.74) for cognitive impairment. CONCLUSION: Low plasma vitamin D levels were associated with greater odds of cognitive impairment. Further prospective studies in Asian populations are needed to examine the causal direction of this association.
OBJECTIVES: To evaluate the association between vitamin D level and cognitive impairment in individuals aged 60 and older. DESIGN: Cross-sectional cohort study. SETTING: Chinese Longitudinal Healthy Longevity Survey, a community-based cohort study in areas in China where the density of centenarians is exceptionally high. PARTICIPANTS: Individuals with mean age of 84.9 ± 12.7 (N = 2,004). MEASUREMENTS: Participants' cognitive state was evaluated using the Mini-Mental State Examination (MMSE). Vitamin D was measured in plasma using an enzyme-linked immunoassay. RESULTS: The cross-sectional association between quartiles of plasma vitamin D level and cognitive impairment (MMSE score <18) was modeled using logistic regressions. Plasma vitamin D levels were lower in individuals with cognitive impairment (31.9 ± 15.3 nmol/L) than in those without (45.6 ± 19.6 nmol/L). There was a reverse association between plasma vitamin D and cognitive impairment. After adjusting for age, sex, chronic conditions, smoking and drinking habits, outdoor activities, depression, and activity of daily living limitations, the association remained significant. The multivariable-adjusted odds ratio for lowest versus highest vitamin D levels was 2.15 (95% confidence interval (CI) = 1.05-4.41) for cognitive impairment, and the multivariable odds ratio associated with a 1-standard deviation decrement in plasma vitamin D was 1.32 (95% CI = 1.00-1.74) for cognitive impairment. CONCLUSION: Low plasma vitamin D levels were associated with greater odds of cognitive impairment. Further prospective studies in Asian populations are needed to examine the causal direction of this association.
Authors: John P Forman; Heike A Bischoff-Ferrari; Walter C Willett; Meir J Stampfer; Gary C Curhan Journal: Hypertension Date: 2005-09-06 Impact factor: 10.190
Authors: Consuelo H Wilkins; Yvette I Sheline; Catherine M Roe; Stanley J Birge; John C Morris Journal: Am J Geriatr Psychiatry Date: 2006-12 Impact factor: 4.105
Authors: M Y Zhang; R Katzman; D Salmon; H Jin; G J Cai; Z Y Wang; G Y Qu; I Grant; E Yu; P Levy Journal: Ann Neurol Date: 1990-04 Impact factor: 10.422
Authors: J van der Schaft; H L Koek; E Dijkstra; H J J Verhaar; Y T van der Schouw; M H Emmelot-Vonk Journal: Ageing Res Rev Date: 2013-05-29 Impact factor: 10.895
Authors: May A Beydoun; Sharmin Hossain; Marie T Fanelli-Kuczmarski; Hind A Beydoun; Jose-Atilio Canas; Michele K Evans; Alan B Zonderman Journal: J Clin Endocrinol Metab Date: 2018-04-01 Impact factor: 5.958
Authors: David B Matchar; Choy-Lye Chei; Zhao-Xue Yin; Victoria Koh; Bibhas Chakraborty; Xiao-Ming Shi; Yi Zeng Journal: J Gerontol A Biol Sci Med Sci Date: 2016-07-12 Impact factor: 6.053
Authors: Neha Sahasrabudhe; Jong Soo Lee; Tammy M Scott; Laura Punnett; Katherine L Tucker; Natalia Palacios Journal: J Nutr Date: 2020-12-10 Impact factor: 4.798